Sysnav provides SV95C, the first regulatory-qualified real-world digital endpoint.
CONTACT
Sysnav Healthcare team smiling in front of a scientific poster on DMD at the International Congress of Myology 2024

News and White papers

The latest news at Sysnav Healthcare

Sysnav Healthcare is exhibiting in ECTRIMS 2023

Events

9 Oct 2023

Sysnav Healthcare at ECTRIMS-ACTRIMS 2023

Sysnav Healthcare is thrilled to be participating in the 9th Joint ECTRIMS-ACTRIMS Meeting.
SV95C primary qualification as a primary endpoint for clinical trials in DMD

Events

8 Aug 2023

EMA Approves SV95C as Primary Endpoint in DMD

EMA opinion marks the first qualification of a digital outcome measure for use as a primary endpoint in pivotal drug trials
SYSNAV Healthcare Announces EMA Primary Endpoint Qualification of Stride Velocity 95th Centile (SV95C) for Duchenne Muscular Dystrophy

News

8 Aug 2023

SYSNAV Healthcare Announces EMA Primary Endpoint Qualification of Stride Velocity 95th Centile (SV95C) for Duchenne Muscular Dystrophy 

EMA opinion marks the first qualification of a digital outcome measure for use as a primary endpoint in pivotal drug trials
Sysnav Healthcare announces a multi-year collaboration with Roche based on Sysnav's proprietary movement tracking technology

News

25 Jan 2023

Sysnav Healthcare announces a multi-year collaboration with Roche

The partnership aims to facilitate development of industry standard outcome measurements in diseases associated with movement impairments
CONTACT